Basic principles of dietary therapy in type 2 diabetes mellitus: focus on antioxidant protection and endothelial dysfunction
AbstractOxidative stress and endothelial dysfunction have been identified as the most important pathogenetic pathways for the development and progression of vascular complications in type 2 diabetes (T2DM).
Objective. To evaluate the effect of individual dietary components on oxidative stress and endothelial dysfunction in patients with T2DM.
Material and methods. The search and analysis of publications was carried out using the PubMed, MEDLINE, Web of Science databases, mainly for the last 10 years, using the keywords “type 2 diabetes mellitus”, “endothelial dysfunction”, “polyphenols”, “antioxidants”, “diet”.
Results. It has been shown that despite the progress in the development of drugs for the correction of clinical and metabolic disorders in T2DM, diet therapy is an important therapeutic factor influencing the main mechanisms of development and progression of cardiovascular complications in T2DM, including hyperglycemia, dyslipidemia, arterial hypertension, subclinical inflammation, endothelial dysfunction. Properly organized and built on modern scientific principles, clinical nutrition improves glycemic control, correction of arterial hypertension, dyslipidemia and overweight/obesity. Influencing the mechanisms of development of oxidative stress, therapeutic nutrition can serve as a preventive approach to protect against the occurrence of endothelial dysfunction and subsequent complications, primarily atherosclerotic origin.
Conclusion. The review presents current data on the effect of diet therapy on the main clinical and metabolic parameters in T2DM, endothelial function and oxidative stress, as the most significant factors in the development of systemic vascular complications.
Keywords:type 2 diabetes mellitus; antioxidant protection; endothelial dysfunction; nutrition; polyphenols
Funding. Research was carried out at the expense of the state budget for the implementation of the state assignment.
Conflict of interest. The authors declare no conflicts of interest.
Contribution. Material collection, writing the text – Alekseev V.A.; interpretation and analysis of literature data – Plotnikova O.A.; editing, approval of the final version of the article – Sharafetdinov Kh.Kh.
For citation: Alekseev V.A., Sharafetdinov Kh.Kh., Plotnikova O.A. Basic principles of dietary therapy in type 2 diabetes mellitus: focus on antioxidant protection and endothelial dysfunction. Voprosy pitaniia [Problems of Nutrition]. 2022; 91 (4): 6–18. DOI: https://doi.org/10.33029/0042-8833-2022-91-4-6-18 (in Russian)
Received 04.05.2021. Accepted 01.07.2022.
References
1. World Health Organization. NCD Mortality and Morbidity. Geneva: World Health Organization, 2018.
2. IDF Diabetes Atlas 2021. 10th ed. URL: https://diabetesatlas.org/atlas/tenth-edition/
3. Clinical recommendations. Algorithms of specialized medical care for patients with diabetes mellitus. Edited by I.I. Dedov, M.V. Shestakova, A.Yu. Mayorov. 10th ed. (updated). Moscow, 2021. DOI: https://doi.org/10.14341/DM20171S8 ISBN 978-5-6043776-5-9 (in Russian)
4. WHO. Double-Duty Actions for Nutrition: Policy Brief. Geneva: World Health Organization, 2017.
5. Toi P.L., Anothaisintawee T., Chaikledkaew U., Briones J.R., Reutrakul S., Thakkinstian A. Preventive role of diet interventions and dietary factors in type 2 diabetes mellitus: an umbrella review. Nutrients. 2020; 12 (9): 2722. DOI: https://doi.org/10.3390/nu12092722
6. Christensen A.A., Gannon M. The beta cell in type 2 diabetes. Curr Diabetes Rep. 2019; 19 (9): 81. DOI: https://doi.org/10.1007/s11892-019-1196-4
7. GBD 2015 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016; 388 (10 053): 1659–724. DOI: https://doi.org/10.1016/S0140-6736(16)31679-8
8. Forouhi N.G., Misra A., Mohan V., Taylor R., Yancy W. Dietary and nutritional approaches for prevention and management of type 2 diabetes. BMJ. 2018; 361: k2234. DOI: https://doi.org/10.1136/bmj.k2234
9. American Diabetes Association. 5. Lifestyle management: standards of medical care in diabetes – 2019. Diabetes Care. 2019; 42 (suppl 1): S46–60. DOI: https://doi.org/10.2337/dc19-s005
10. Utami D.B., Findyartini A. Plant-based diet for HbA1c reduction in type 2 diabetes mellitus: an evidence-based case report. Acta Med Indones. 2018; 50 (3): 260–7.
11. Apolzan J.W., Venditti E.M., Edelstein S.L., Knowler W.C., Dabelea D., Boyko E.J., et al. Long-term weight loss with metformin or lifestyle intervention in the diabetes prevention program outcomes study. Ann Intern Med. 2019; 170 (10): 682–90. DOI: https://doi.org/10.7326/M18-1605
12. Briggs Early K., Stanley K. Position of the Academy of Nutrition and Dietetics: the role of medical nutrition therapy and registered dietitian nutritionists in the prevention and treatment of prediabetes and type 2 diabetes. J Acad Nutr Diet. 2018; 118 (2): 343–53. DOI: https://doi.org/10.1016/j.jand.2017.11.021
13. Ojo O. Dietary intake and type 2 diabetes. Nutrients. 2019; 11 (9): 2177. DOI: https://doi.org/10.3390/nu11092177
14. Franz M.J. Diabetes nutrition therapy: effectiveness, macronutrients, eating patterns and weight management. Am J Med Sci. 2016; 351 (4): 374–9. DOI: https://doi.org/10.1016/j.amjms.2016.02.001
15. Franz M.J., MacLeod J., Evert A., Brown C., Gradwell E., Handu D., et al. Academy of Nutrition and Dietetics nutrition practice guideline for type 1 and type 2 diabetes in adults: systematic review of evidence for medical nutrition therapy effectiveness and recommendations for integration into the nutrition care process. J Acad Nutr Diet. 2017; 117 (10): 1659–79. DOI: https://doi.org/10.1016/j.jand.2017.03.022
16. Ampofo D., Agbenorhevi J.K., Firempong C.K., Adu-Kwarteng E. Glycemic index of different varieties of yam as influenced by boiling, frying and roasting. Food Sci Nutr. 2020; 9 (2): 1106–111. DOI: https://doi.org/10.1002/fsn3.2087
17. Nicholls J. Perspective: the Glycemic Index falls short as a carbohydrate food quality indicator to improve diet quality. Front Nutr. 2022; 9: 896333. DOI: https://doi.org/10.3389/fnut.2022.896333
18. Marshall S., Petocz P., Duve E., Abbott K., Cassettari T., Blumfield M., et al. The effect of replacing refined grains with whole grains on cardiovascular risk factors: a systematic review and meta-analysis of randomized controlled trials with GRADE clinical recommendation. J Acad Nutr Diet. 2020; 120 (11): 1859–83.e31. DOI: https://doi.org/10.1016/j.jand.2020.06.021
19. Jung C.H., Choi K.M. Impact of high-carbohydrate diet on metabolic parameters in patients with type 2 diabetes. Nutrients. 2017; 9 (4): 322. DOI: https://doi.org/10.3390/nu9040322
20. Tay J., Luscombe-Marsh N.D., Thompson C.H., Noakes M., Buckley J.D., Wittert G.A., et al. Comparison of lowand high-carbohydrate diets for type 2 diabetes management: a randomized trial. Am J Clin Nutr. 2015; 102 (4): 780–90. DOI: https://doi.org/10.3945/ajcn.115.112581
21. Yamada S. Paradigm shifts in nutrition therapy for type 2 diabetes. Keio J Med. 2017; 66 (3): 33–43. DOI: https://doi.org/10.2302/kjm.2016-0016-IR
22. Qian F., Korat A.A., Malik V. Hu F.B. Metabolic effects of monounsaturated fatty acid–enriched diets compared with carbohydrate or polyunsaturated fatty acid-enriched diets in patients with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. Diabetes Care. 2016; 39 (8): 1448–57. DOI: https://doi.org/10.2337/dc16-0513
23. de Souza R.J., Mente A., Maroleanu A., Cozma A.I., Ha V., Kishibe T., et al. Intake of saturated and trans unsaturated fatty acids and risk of all cause mortality, cardiovascular disease, and type 2 diabetes: systematic review and meta-analysis of observational studies. BMJ. 2015; 351: h3978. DOI: https://doi.org/10.1136/bmj.h3978
24. Guasch-Ferre M., Babio N., Martınez-Gonzalez M.A., Corella D., Ros E., Martín-Peláez S., et al. Dietary fat intake and risk of cardiovascular disease and all-cause mortality in a population at high risk of cardiovascular disease. Am J Clin Nutr. 2015; 102 (6): 1563–73. DOI: https://doi.org/10.3945/ajcn.115.116046
25. Huo R., Du T., Xu Y., Xu W., Chen X., Sun K., et al. Effects of Mediterranean-style diet on glycemic control, weight loss and cardiovascular risk factors among type 2 diabetes individuals: a meta-analysis. Eur J Clin Nutr. 2015; 69 (11): 1200–8. DOI: https://doi.org/10.1038/ejcn.2014.243
26. Wu J.H.Y., Marklund M., Imamura F., Tintle N., Ardisson Korat A.V., de Goede J.; Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Fatty Acids and Outcomes Research Consortium (FORCE). Omega-6 fatty acid biomarkers and incident type 2 diabetes: pooled analysis of individual-level data for 39 740 adults from 20 prospective cohort studies. Lancet Diabetes Endocrinol. 2017; 5 (12): 965–74. DOI: https://doi.org/10.1016/S2213-8587(17)30307-8
27. U.S. Department of Health and Human Service; U.S. Department of Agriculture. 2015–2020 Dietary Guidelines for Americans. 9th edition [Internet], 2015. URL: https://www.dietaryguidelines.gov/resources/2020-2025-dietary-guidelines-online-materials
28. Mozaffarian D. Dietary and policy priorities for cardiovascular disease, diabetes, and obesity: a comprehensive review. Circulation. 2016; 133 (2): 187–225. DOI: https://doi.org/10.1161/CIRCULATIONAHA.115.018585
29. Johnston B.C., Kanters S., Bandayrel K., Wu P., Naji F., Siemieniuk R.A. Comparison of weight loss among named diet programs in overweight and obese adults: a meta-analysis. JAMA. 2014; 312 (9): 923–33. DOI: https://doi.org/10.1001/jama.2014.1039725182101
30. Evert A.B., Dennison M., Gardner C.D., Garvey W.T., Lau K.H.K., MacLeod J. Nutrition therapy for adults with diabetes or prediabetes: a consensus report. Diabetes Care. 2019; 42 (5): 731–54. DOI: https://doi.org/10.2337/dci19-0014
31. Estruch R., Ros E., Salas-Salvadó J., Covas M.I., Corella D., Arós F.; PREDIMED Study Investigators. Primary prevention of cardiovascular disease with a Mediterranean diet supplemented with extra-virgin olive oil or nuts. N Engl J Med. 2018; 378 (25): e34. DOI: https://doi.org/10.1056/NEJMoa1800389
32. Salas-Salvado J., Bulló M., Estruch R., Ros E., Covas M.I., Ibarrola-Jurado N. Prevention of diabetes with Mediterranean diets: a subgroup analysis of a randomized trial. Ann Intern Med. 2014; 160 (1): 1–10. DOI: https://doi.org/10.7326/M13-1725
33. Pintó X., Fanlo-Maresma M., Corbella E., Corbella X., Mitjavila M.T., Moreno J.J., et al. A Mediterranean diet rich in extra-virgin olive oil is associated with a reduced prevalence of nonalcoholic fatty liver disease in older individuals at high cardiovascular risk. J Nutr. 2019; 149 (11): 1920–9. DOI: https://doi.org/10.1093/jn/nxz147
34. Ros E., Martínez-González M.A., Estruch R., Salas-Salvadó J., Fitó M., Martínez J.A., et al. Mediterranean diet and cardiovascular health: teachings of the PREDIMED study. Adv Nutr. 2014; 5 (3): 330S–6S. DOI: https://doi.org/10.3945/an.113.005389
35. Schwingshackl L., Bogensberger B., Hoffmann G. Diet quality as assessed by the Healthy Eating Index, Alternate Healthy Eating Index, Dietary Approaches to Stop Hypertension score, and health outcomes: an updated systematic review and meta-analysis of cohort studies. J Acad Nutr Diet. 2018; 118: 74–100.e11. DOI: https://doi.org/10.1016/j.jand.2017.08.024
36. World Health Organization. Guideline: Sodium Intake for Adults and Children, 2012.
37. Mason S.A., Keske M.A., Wadley G.D. Effects of vitamin c supplementation on glycemic control and cardiovascular risk factors in people with type 2 diabetes: a GRADE-assessed systematic review and meta-analysis of randomized controlled trials. Diabetes Care. 2021; 44 (2): 618–30. DOI: https://doi.org/10.2337/dc20-1893
38. Moreira-Lucas T.S., Duncan A.M., Rabasa-Lhoret R., Vieth R., Gibbs A.L., Badawi A., et al. Effect of vitamin D supplementation on oral glucose tolerance in individuals with low vitamin D status and increased risk for developing type 2 diabetes (EVIDENCE): a double-blind, randomized, placebo-controlled clinical trial. Diabetes Obes Metab. 2017; 19 (1): 133–41. DOI: https://doi.org/10.1111/dom.12794
39. Aroda V.R., Edelstein S.L., Goldberg R.B., Knowler W.C., Marcovina S.M., Orchard T.J., et al.; Diabetes Prevention Program Research Group. Long-term metformin use and vitamin B12 deficiency in the Diabetes Prevention Program Outcomes Study. J Clin Endocrinol Metab. 2016; 101 (4): 1754–61. DOI: https://doi.org/10.1210/jc.2015-3754
40. Esser N., Legrand-Poels S., Piette J., Scheen A.J., Paquot N. Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes Res Clin Pract. 2014; 105 (2): 141–50. DOI: https://doi.org/10.1016/j.diabres.2014.04.006
41. Tong H.V., Luu N.K., Son H.A., Hoan N.V., Hung T.T., Velavan T.P., et al. Adiponectin and pro-inflammatory cytokines are modulated in Vietnamese patients with type 2 diabetes mellitus. J Diabetes Investig. 2017; 8 (3): 295–305. DOI: https://doi.org/10.1111/jdi.12579
42. Ramallal R., Toledo E., Martínez J.A., Shivappa N., Hébert J.R., Martínez-González M.A., et al. Inflammatory potential of diet, weight gain and incidence of overweight/obesity: the SUN cohort. Obesity (Silver Spring). 2017; 25 (6): 997–1005. DOI: https://doi.org/10.1002/oby.21833
43. Shivappa N., Steck S.E., Hussey J.R., Ma Y., Hebert J.R. Inflammatory potential of diet and all-cause, cardiovascular, and cancer mortality in National Health and Nutrition Examination Survey III Study. Eur J Nutr. 2017; 56 (2): 683–92. DOI: https://doi.org/10.1007/s00394-015-1112-x
44. Dong Y., Wang X., Zhang L., Chen Z., Zheng C., Wang J., et al. High-sensitivity C reactive protein and risk of cardiovascular disease in China-CVD study. J Epidemiol Community Health. 2019; 73 (2): 188–92. DOI: https://doi.org/10.1136/jech-2018-211433
45. Estruch R., Martínez-González M.A., Corella D., Salas-Salvadó J., Fitó M., Chiva-Blanch G., et al. Effect of a high-fat Mediterranean diet on bodyweight and waist circumference: a prespecified secondary outcomes analysis of the PREDIMED randomised controlled trial. Lancet Diabetes Endocrinol. 2019; 7 (5): e6–17. DOI: https://doi.org/10.1016/S2213-8587(19)30074-9
46. Medina-Remón A., Casas R., Tressserra-Rimbau A., Ros E., Martínez-González M.A., Fitó M., et al. Polyphenol intake from a Mediterranean diet decreases inflammatory biomarkers related to atherosclerosis: a sub-study of The PREDIMED trial. Br J Clin Pharmacol. 2017; 83 (1): 114–28. DOI: https://doi.org/10.1111/bcp.12986
47. Herieka M., Faraj T.A., Erridge C. Reduced dietary intake of pro-inflammatory Toll-like receptor stimulants favourably modifies markers of cardiometabolic risk in healthy men. Nutr Metab Cardiovasc Dis. 2016; 26: 194–200. DOI: https://doi.org/10.1016/j.numecd.2015.12.001
48. Schwingshackl L., Hoffmann G. Mediterranean dietary pattern, inflammation and endothelial function: a systematic review and meta-analysis of intervention trials. Nutr Metab Cardiovasc Dis. 2014; 24: 929–39. DOI: https://doi.org/10.1016/j.numecd.2014.03.003
49. Schwingshackl L., Christoph M., Hoffmann G. Effects of olive oil on markers of inflammation and endothelial function – a systematic review and meta-analysis. Nutrients. 2015; 7 (9): 7651–75. DOI: https://doi.org/10.3390/nu7095356
50. Fraga C.G., Croft K.D., Kennedy D.O., Tomás-Barberán F.A. The effects of polyphenols and other bioactives on human health. Food Funct. 2019; 10 (2): 514–28. DOI: https://doi.org/10.1039/c8fo01997e
51. Reuland D.J., Khademi S., Castle C.J., Irwin D.C., McCord J.M., Miller B.F., et al. Upregulation of phase II enzymes through phytochemical activation of Nrf2 protects cardiomyocytes against stress. Free Radic Biol Med. 2013; 56: 102–11. DOI: https://doi.org/10.1016/j.freeradbiomed.2012.11.016
52. Kim I.S., Hwang C.W., Yang W.S., Kim C.H. Current perspectives on the physiological activities of fermented soybean-derived Cheonggukjang. Int J Mol Sci. 2021; 22 (11): 5746. DOI: https://doi.org/10.3390/ijms22115746
53. Nicastro H.L., Mondul A.M., Rohrmann S., Platz E.A. Associations between urinary soy isoflavonoids and two inflammatory markers in adults in the United States in 2005–2008. Cancer Causes Control. 2013; 24 (6): 1185–96. DOI: https://doi.org/10.1007/s10552-013-0198-9
54. Carlström M., Larsson S.C. Coffee consumption and reduced risk of developing type 2 diabetes: a systematic review with meta-analysis. Nutr Rev. 2018; 76 (6): 395–417. DOI: https://doi.org/10.1093/nutrit/nuy014
55. Kabeya Y., Goto A., Kato M., Takahashi Y., Isogawa A., Matsushita Y., et al. Cross-sectional associations between the types/amounts of beverages consumed and the glycemia status: the Japan Public Health Center-based Prospective Diabetes study. Metabol Open. 2022; 14: 100185. DOI: https://doi.org/10.1016/j.metop.2022.100185
56. Akash M.S., Rehman K., Chen S. Effects of coffee on type 2 diabetes mellitus. Nutrition. 2014; 30 (7–8): 755–63. DOI: https://doi.org/10.1016/j.nut.2013.11.020
57. Natella F., Scaccini C. Role of coffee in modulation of diabetes risk. Nutr Rev. 2012; 70 (4): 207–17. DOI: https://doi.org/10.1111/j.1753-4887.2012.00470.x
58. Den Hartogh D.J., Gabriel A., Tsiani E. Antidiabetic properties of curcumin ii: evidence from in vivo studies. Nutrients. 2019; 12 (1): 58. DOI: https://doi.org/10.3390/nu12010058
59. Carvalho G.C.N., Lira-Neto J.C.G., Araújo M.F.M., Freitas R.W.J.F., Zanetti M.L., Damasceno M.M.C. Effectiveness of ginger in reducing metabolic levels in people with diabetes: a randomized clinical trial. Rev Lat Am Enfermagem. 2020; 28: e3369. DOI: https://doi.org/10.1590/1518-8345.3870.3369
60. Pivari F., Mingione A., Brasacchio C., Soldati L. Curcumin and type 2 diabetes mellitus: prevention and treatment. Nutrients. 2019; 11 (8): 1837. DOI: https://doi.org/10.3390/nu11081837
61. Yuan F., Wu W., Ma L., Wang D., Hu M., Gong J., et al. Turmeric and curcuminiods ameliorate disorders of glycometabolism among subjects with metabolic diseases: a systematic review and meta-analysis of randomized controlled trials. Pharmacol Res. 2022; 177: 106121. DOI: https://doi.org/10.1016/j.phrs.2022.106121
62. Panahi Y., Khalili N., Sahebi E., Namazi S., Reiner Ž., Majeed M., et al. Curcuminoids modify lipid profile in type 2 diabetes mellitus: a randomized controlled trial. Complement Ther Med. 2017; 33: 1–5. DOI: https://doi.org/10.1016/j.ctim.2017.05.006
63. Morvaridzadeh M., Fazelian S., Agah S., Khazdouz M., Rahimlou M., Agh F., et al. Effect of ginger (Zingiber officinale) on inflammatory markers: a systematic review and meta-analysis of randomized controlled trials. Cytokine. 2020; 135: 155224. DOI: https://doi.org/10.1016/j.cyto.2020.155224
64. Mahdavi A., Bagherniya M., Mirenayat M.S., Atkin S.L., Sahebkar A. Medicinal plants and phytochemicals regulating insulin resistance and glucose homeostasis in type 2 diabetic patients: a clinical review. Adv Exp Med Biol. 2021; 1308: 161–83. DOI: https://doi.org/10.1007/978-3-030-64872-5_13
65. Kaur R., Kaur M., Singh J. Endothelial dysfunction and platelet hyperactivity in type 2 diabetes mellitus: molecular insights and therapeutic strategies. Cardiovasc Diabetol. 2018; 17 (1): 121. DOI: https://doi.org/10.1186/s12933-018-0763-3
66. von Scholten B.J, Reinhard H., Hansen T.W., Schalkwijk C.G., Stehouwer C., Parving H.H., et al. Markers of inflammation and endothelial dysfunction are associated with incident cardiovascular disease, all-cause mortality, and progression of coronary calcification in type 2 diabetic patients with microalbuminuria. J Diabetes Complications. 2016; 30 (2): 248–55. DOI: https://doi.org/10.1016/j.jdiacomp.2015.11.005
67. Daka B., Olausson J., Larsson C.A., Hellgren M.I., Rastam L., Jansson P.A., et al. Circulating concentrations of endothelin-1 predict coronary heart disease in women but not in men: a longitudinal observational study in the Vara-Skövde Cohort. BMC Cardiovasc Disord. 2015; 15: 146. DOI: https://doi.org/10.1186/s12872-015-0141-y
68. Zhito A.V., Yusupova A.O., Privalova E.V., Khabarova N.V., Belenkov Yu.N. Markers of endothelial dysfunction: E-selectin, endothelin-1 and von Willebrand factor in patients with coronary heart disease, including in combination with type 2 diabetes mellitus. Ratsional’naya farmakoterapiya v kardiologii [Rational Pharmacotherapy in Cardiology]. 2019; 15 (6): 892–9. DOI: https://doi.org/10.20996/1819-6446-2019-15-6-892-899 (in Russian)
69. Man A.W.C., Li H., Xia N. Impact of lifestyles (diet and exercise) on vascular health: oxidative stress and endothelial function. Oxid Med Cell Longev. 2020; 2020: 1496462. DOI: https://doi.org/10.1155/2020/1496462
70. Yashin A.Ya., Vedenin A.N., Yashin Ya.I., Vasilevich N.I. Antiviral antioxidant polyphenols: structure, dietary sources, and mechanism of action. Laboratoriya i proizvodstvo [Laboratory and Production]. 2020; 5 (14): 76–84. DOI: https://doi.org/10.32757/2619-0923.2020.5.14.76.86 (in Russian)
71. Da Porto A., Cavarape A., Colussi G., Casarsa V., Catena C., Sechi L.A. Polyphenols rich diets and risk of type 2 diabetes. Nutrients 2021; 13: 1445. DOI: https://doi.org/10.3390/nu13051445
72. Xu H., Luo J., Huang .J, Wen Q. Flavonoids intake and risk of type 2 diabetes mellitus: a meta-analysis of prospective cohort studies. Medicine (Baltimore). 2018; 97 (19): e0686. DOI: https://doi.org/10.1097/MD.0000000000010686
73. Fallah A.A., Sarmast E., Jafari T. Effect of dietary anthocyanins on biomarkers of glycemic control and glucose metabolism: a systematic review and meta-analysis of randomized clinical trials. Food Res Int. 2020; 137: 109379. DOI: https://doi.org/10.1016/j.foodres.2020.109379
74. Gorzynik-Debicka M., Przychodzen P., Cappello F., Kuban-Jankowska A., Marino Gammazza A., Knap N. Potential health benefits of olive oil and plant polyphenols. Int J Mol Sci. 2018; 19 (3): 686. DOI: https://doi.org/10.3390/ijms19030686
75. Castaldo L., Narváez A., Izzo L., Graziani G., Gaspari A., Minno G.D. Red wine consumption and cardiovascular health. Molecules. 2019; 24 (19): 3626. DOI: https://doi.org/10.3390/molecules24193626
76. Murillo A.G,. Fernandez M.L. The relevance of dietary polyphenols in cardiovascular protection. Curr Pharm Des. 2017; 23 (17): 2444–52. DOI: https://doi.org/10.2174/1381612823666170329144307
77. Plant sources of phytonutrients for specialized antidiabetic foods. Edited by V.A. Tutelyan, T.L. Kiseleva, A.A. Kochetkova. Moscow: BIBLIO-GLOBUS, 2016: 422 p. ISBN 978-5-9909097-5-5. (in Russian)